TOBRAMYCIN INJECTION USP 40mg/ml recall in Canada: Out of specification
In plain language
This recall involves TOBRAMYCIN INJECTION USP 40mg/ml sold in Canada. It's being recalled because the antioxidant assay results are out of specification. Stop using the product and follow the return steps in the official notice.
What to do
- Stop using the product immediately.
- Check the lot number.
- Contact Sterimax Inc. for more information.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
TOBRAMYCIN INJECTION USP 40mg/ml
Lot: AEP002
Why this matters
Product safety issue
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
- 2
Check the lot number
Lot numbers identify specific production batches.
Affected lots: AEP002
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
Product safety issue
What should consumers do?
Stop using the product immediately. Check the lot number. Contact Sterimax Inc. for more information.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Product safety issue
When was this product recalled?
This product was recalled on June 21, 2021.